| Amber Enterprises |
Reported ₹32 cr loss in Q2FY26; EBITDA margin slipped 120 bps to 5.9%. |
| BHEL |
BHEL surged after bagging a ₹6,650 cr EPC order from NTPC to set up an 800 MW thermal power plant in Odisha. |
| Welspun Enterprises Ltd |
Welspun Enterprises gained after receiving a ₹3,145 cr LoA from BMC to build a 910 MLD water treatment plant in Mumbai. |
| Life Insurance Corporation of India |
LIC reported a 5.5% YoY rise in Q2FY26 net premium income to ₹1.3 lakh crore. |
| Alembic pharma |
Alembic Pharma received USFDA final approval for its Dasatinib tablets (20 mg–140 mg), clearing the way to market the cancer treatment drug across multiple strengths in the US. |